[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2002020493A2 - A traceless solid-phase synthesis of 2-imidazolones - Google Patents

A traceless solid-phase synthesis of 2-imidazolones Download PDF

Info

Publication number
WO2002020493A2
WO2002020493A2 PCT/US2001/027207 US0127207W WO0220493A2 WO 2002020493 A2 WO2002020493 A2 WO 2002020493A2 US 0127207 W US0127207 W US 0127207W WO 0220493 A2 WO0220493 A2 WO 0220493A2
Authority
WO
WIPO (PCT)
Prior art keywords
polymer
bound
acetal
formula
haloacetaldehyde
Prior art date
Application number
PCT/US2001/027207
Other languages
French (fr)
Other versions
WO2002020493A3 (en
Inventor
Jie Fei Cheng
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Priority to AU2001288605A priority Critical patent/AU2001288605A1/en
Publication of WO2002020493A2 publication Critical patent/WO2002020493A2/en
Publication of WO2002020493A3 publication Critical patent/WO2002020493A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/30Introducing nitrogen atoms or nitrogen-containing groups

Definitions

  • This invention relates to a novel process for preparing 2-imidazolones compounds.
  • This invention also relates to novel polymer-bound halo- and amino- acetaldehyde acetal compounds.
  • This invention also relates to a novel process for preparing polymer-bound halo- and amino-acetaldehyde acetal compounds.
  • BACKGROUND 2-lmidazolone derivatives have long been known to possess interesting biological activities. Examples include herbicial agents (R. W. Luckenbaugh, US 3,216,816), antifungal agents (Itoh, K. et al., EP 884,311 ), anti-coagulants (Mohan, R.
  • this invention provides a process for preparing a 2- imidazolone compound of the formula (I)
  • said acid in the step 4) is trifluoroacetic acid or hydrochloric acid.
  • this invention also provides a polymer-bound haloacetaldehyde acetal compound of formula (IV), wherein x is chloro, bromo or iodo.
  • this invention also provides a process for preparing a polymer-bound haloacetaldehyde acetal compound of formula (IV) by reacting a haloacetaldehyde diethyl acetal (III) with a polymer-bound 1 ,2-ethylenediol under acidic conditions, wherein x is chloro, bromo or iodo.
  • this invention also provides a polymer-bound aminoacetaldehyde acetal compound of formula (V), wherein Ri represents hydrogen, alkyl, heterocyclyl, aryl, or heteroaryl groups.
  • this invention also provides a process for preparing a polymer-bound aminoacetaldehyde acetal compound of formula (V) by reacting a polymer-bound haloacetaldehyde acetal (IV) with a primary amine of the formula
  • R ⁇ NH 2 wherein Ri represents hydrogen, alkyl, heterocyclyl, aryl, or heteroaryl groups.
  • reaction of a haloacetaldehyde diethyl acetal with a polymer-bound 1 ,2-ethylenediol affords the polymer-bound haloacetaldehyde acetal (IV).
  • the acids that make acidic conditions in this reaction include but not limited to p-toluenesulfonic acid, camphor sulfonic acid, hydrochloric acid and Lewis acids.
  • the preferred acid is camphor sulfonic acid.
  • the polymer-bound 1 ,2-ethylenediol is purchased from commercial sources
  • a polymer-bound glycerol may be prepared from a polymer through derivatization.
  • a polymer-bound glycerol can be prepared from a polymer and a glycerol derivative (Lenzoff, C.C. et al., Can. J. Chem. 51 ,
  • Reaction of a polymer-bound haloacetaldehyde acetal (IV) with a primary amine of the formula R 1 NH 2 in a solvent forms a polymer-bound aminoacetaldehyde acetal (V).
  • solvent used for this reaction step, except that the amine RiNH 2 be at least somewhat soluble therein.
  • most organic solvents such as DMSO, DMF or toluene can be utilized successfully for the reaction.
  • DMSO is the preferred solvent.
  • the reaction is conducted at the elevated temperature, for example, at 80°C.
  • Reaction of a polymer-bound aminoacetaldehyde acetal (V) with isocyanates of the formula R 2 NCO gives a urea acetaldehyde acetal intermediate (VI) under a variety of conditions.
  • the reaction goes smoothly in solvents such as THF, CH 2 CI 2 or toluene.
  • the reaction can be conducted in the presence or absence of bases.
  • the reaction was preferably conducted at 60°C in toluene in the presence of DMAP or DIPEA.
  • This process described in the invention could be useful for making a large number of compounds for, but not limited to, high-throughput screening.
  • One of the potential advantages of this reaction is that it yields a reusable polymer along with the product.
  • This invention also provides a polymer-bound haloacetaldehyde acetal compound of formula (IV), wherein x is chloro, bromo or iodo, which may be prepared by the process described throughout this specification.
  • This polymer- bound haloacetaldehyde is a useful intermediate in preparing compounds with aldehyde functionalities or the like.
  • This invention also provides a polymer-bound aminoacetaldehyde acetal compound of formula (V), wherein Ri represents hydrogen, alkyl, heterocyclyl, aryl, or heteroaryl groups, which is a useful intermediate in preparing compounds with aldehyde and/or amino functionalities.
  • Acid means an acid that facilitates acetal hydrolysis. It includes organic acids such as trifluoroacetic acid, p-toluenesulfonic acid, acetic acid, formic acid or inorganic acids such as hydrohalic acids.
  • organic acids such as trifluoroacetic acid, p-toluenesulfonic acid, acetic acid, formic acid or inorganic acids such as hydrohalic acids.
  • the preferred acid in the invention for the cleavage (hydrolysis) of acetal functionality from the solid support is trifluoroacetic acid or hydrochloric acid.
  • Acid labile linkage means the link between an organic molecule and a solid support (or polymer, resin) can be removed or cleaved by treatment with an acid while remaining stable to other reagents.
  • acid labile linkage include ether or ester bond on Wang resin (Wang, S.-S. J. Am. Chem. Soc. 95, 1328 (1973)), amide bond on Rink resin (Rink, H., Tetrahedron Lett. 28, 3787 (1987)), or acetal on the polymer as described in the invention.
  • Preferred acids to cleave the product from these polymers (resins) are trifluoroacetic acid (TFA) or HF.
  • Alkyl as used herein, means a cyclic, branched, or straight chain chemical group containing only carbon and hydrogen, such as methyl, pentyl, and adamantyl. Alkyl groups can either be unsubstituted or substituted with one or more substituents, e.g., halogen, alkoxy, acyloxy, amino, cyano, nitro, hydroxyl, mercapto, carboxy, benzyloxy, aryl, heteroaryl, or other functionality that may be suitably blocked, if necessary for purposes of the invention, with a protecting group.
  • substituents e.g., halogen, alkoxy, acyloxy, amino, cyano, nitro, hydroxyl, mercapto, carboxy, benzyloxy, aryl, heteroaryl, or other functionality that may be suitably blocked, if necessary for purposes of the invention, with a protecting group.
  • Aryl as used herein, means a monovalent unsaturated aromatic carbocyclic group having a single-ring (e.g., phenyl) or multiple condensed rings (e.g., naphthyl or anthryl), which can be optionally unsubstituted or substituted with amino, cyano, hydroxyl, lower alkyl, haloalkyl, alkoxy, nitro, halo, mercapto, and other substituents.
  • Halo as used herein, means chloro, bromo or iodo atoms in the invention.
  • the fluorine atom is excluded in the invention.
  • Heteroaryl as used herein, means a monovalent unsaturated aromatic carbocyclic group having a single ring (e.g., pyrridyl or furyl) or multiple condensed rings (e.g., indolizinyl or benzothienyl) and having at least one hetero atom, such as N, O, or S, within the ring, which can optionally be unsubstituted or substituted with amino, cyano, nitro, hydroxyl, alkyl, haloalkyl, alkoxy, aryl, halo, mercapto, and other substituents.
  • Heterocyclyl as used herein, means radical heterocycles which are saturated, or unsaturated and non-aromatic.
  • heterocycles are of 5 or 6 members.
  • the heteroatom(s) are from one to three Ns, and wherein when the heterocycle is five membered and non-aromatic, preferably it has one or two heteroatoms selected from O, N, or S.
  • Polymer-bound 1 ,2-ethylenediol as used herein, means that 1 ,2-dihydroxyl ethane unit is linked through an ethylene carbon to a polymer via any stable linkage.
  • protecting group means a chemical group that exhibits the following characteristics: (I) reacts selectively with the desired functionality in good yield to give a protected substrate that is stable to the projected reactions for which protection is desired; 2) is selectively removable from the protected substrate to yield the desired functionality; and 3) is removable in good yield by reagents compatible with the other functional group(s) generated in such protected reactions. Examples of protecting groups can be found in Greene and Wuts, Protective Groups in Organic Synthesis, 2 nd Ed. John Wiley & Sons, (1991 ).
  • Solid-phase synthesis means a heterogeneous reaction in which one of reactants is covalently connected to a solid support (polymer or resin, etc.). Other reactants are dissolved in an organic solvent or solvents and the product is obtained through a cleavage step from the solid support.
  • Solid support means a substrate which is inert to the reagents and reaction conditions described herein, as well as being substantially insoluble in the media used.
  • Representative solid supports include inorganic substrates such as kieselguhr, silica gel, and controlled pore glass; organic polymers including polystyrene, polypropylene, polyethylene glycol, polyacrylamide, cellulose, and the like; and composite inorganic/polymeric compositions such as polyacrylamide supported within a matrix of kieselguhr particles. See J.M. Stewart and J.D. Young, Solid Phase Peptide Synthesis, 2nd. Ed., Pierce Chemical Co. (Chicago, IL, 1984). A polymer is preferably used in this invention.
  • solid support includes polymeric supports such as the polyethylene glycol supports described by Janda et al., Proc. Natl. Acad. Sci. USA, 92, 6419-6423 (1995) and S. Brenner, WO 95/16918, which are soluble in many solvents but can be precipitated
  • the solid support is designated as ⁇ - ⁇ in this specification.
  • solvent means a liquid that can dissolve another compound and has no adverse effect on the reaction or on the reagents involved.
  • suitable solvents include alcohols (methanol, 1 -butanol, phenol, trifluoroethanol, hexafluoro-2-propanol, etc.), hydrocarbons (benzene, toluene, etc.), amides (dimethyl acetamide, dimethylformamide, etc.), halides (dichloromethane, dichloroethane, etc.), and ethers (tetrahydrofuran, dioxane, etc.).
  • Other solvents include water, 1 -methyl-2-pyrrol ⁇ dine, diethyl phosphite, tetramethaylsulphone, dimethyl sulphoxide, acetonitrile and pyridine.
  • Raceies solid-phase synthesis means that a solid-phase synthesis that leaves no trace of the linker used for tethering the starting building blocks to the solid support.
  • Under acidic conditions means the acetal formation reaction is conducted in the presence of an acid which itself is not part of the reactant.
  • the acid can be either inorganic acids such as hydrochloric acid, sulfuric acid or Lewis acids or organic acids such as trifluoroacetic acid, p-toluenesulfonic acid, camphor sulfonic acid. Preferred acids are camphor sulfonic acid or any Lewis acids.
  • CDCI 3 deutered chloroform
  • DIPEA diisopropylethyl amine
  • MgSO magnesium sulfate
  • TFA trifluoroacetic acid
  • THF tetrahydrofuran
  • TLC thin layer chromatography The following alkyl group abbreviations are used.
  • H nuclear magnetic resonance spectra is measured in CDCI 3 or other solvents as indicated by a Varian NMR spectrometer (Unity Plus 400, 400 MHz for 1 H) unless otherwise indicated and peak positions are expressed in parts per million (ppm) downfield from tetramethylsilane.
  • the peak shapes are denoted as follows, s, singlet; d, doublet; t, triplet; m, multiplet.
  • the polymer that used in the reaction is a commercially available polymer- bound glycerol (II).
  • Acetal exchange of a haloacetaldehyde diethyl acetal such as bromoacetaldehyde diethyl acetal with the polymer-bound glycerol affords the polymer-bound haloacetaldehyde acetal (IV) in the presence of camphor sulfonic acid in CH2CI 2 at room temperature.
  • the formation of the halide on the solid support is confirmed by infrared spectrometric analysis and weight change of the resin.
  • CSA (1 eq.) was added followed by 2-bromoacetaldehyde diethyl acetal (10 eq) to the suspension of polymer-bound glycerol (250 mg, 1.38 mmol/g, Aldrich) in CH 2 CI 2 (3 mL) in a 10 mL tube with frit and screw cap.
  • the suspension was shaken in a shaker at room temperature for 12 h.
  • the solvent was drained, and the polymer was washed with DMF (3 x 6 mL), MeOH (3 x 6 mL) and CH 2 CI 2 (3 x 6 mL) and dried under vacuum at room temperature.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Formula (I) A traceless solid-phase synthesis of 2-imidazolones is described. A polymer-bound haloacetaldehyde acetal, which is prepared from an acetal exchange of haloacetaldehyde diethyl acetal with polymer-bound 1,2-ethylenediol, is reacted with a primary amine of the formula R1NH2 to afford a polymer-bound aminoacetaldehyde acetal. The latter is reacted with an isocyanate of the formula R2NCO to afford the corresponding polymer-bound urea acetal intermediate, which upon treatment with an acid provides the 2-imidazolone compounds.

Description

SPECIFICATION
A TRACELESS SOLID-PHASE SYNTHESIS OF 2-IMIDAZOLONES
FIELD OF THE INVENTION This invention relates to a novel process for preparing 2-imidazolones compounds. This invention also relates to novel polymer-bound halo- and amino- acetaldehyde acetal compounds. This invention also relates to a novel process for preparing polymer-bound halo- and amino-acetaldehyde acetal compounds. BACKGROUND 2-lmidazolone derivatives have long been known to possess interesting biological activities. Examples include herbicial agents (R. W. Luckenbaugh, US 3,216,816), antifungal agents (Itoh, K. et al., EP 884,311 ), anti-coagulants (Mohan, R. et al., WO 96/38421) and PDE IV inhibitors (Freyne, E. J. E. et al., WO 96/31485). Several synthetic procedures for preparing 2-imidazolones have been described in the literature (Lehmstedt et al., J. Liebigs, Ann. Chem. 456, 269 (1927); R. Duschinsky, E. Fell, US 2,707,186; W. B. Wright Jr. et al., US 3,355,457; R. W. Luckenbaugh, US 3,216,816). The most convenient of these is an intramolecular N- acyliminium ion cyclization of a urea acetaldehyde acetal precursor. Under acidic conditions, the acetal protecting group of the urea acetaldehyde acetal is removed and the resulting urea acetaldehyde intermediate formed. Subsequently, urea acetaldehyde cyclizes to afford a five-membered Λ/-acyliminium ion which spontaneously deprotonates to afford the 2-imidazolone in the absence of any nucleophiles. However, this reaction takes place in the solution phase. It does not appear that such a reaction can be adapted for use in a traceiess solid-phase synthesis of 2-imidazolones. SUMMARY OF THE INVENTION
I have found that a urea acetaldehyde acetal mounted on a solid support under acidic conditions releases a urea acetaldehyde intermediate from the solid support and simultaneously undergoes cyclization and deprotonation to afford the 2- imidazolone. Thus, 2-imidazolones prepared by this solid-phase method leave no trace of the linker used for tethering the starting material to the solid support. In one aspect, this invention provides a process for preparing a 2- imidazolone compound of the formula (I)
Figure imgf000003_0001
(I) comprising the steps of
1 ) Reacting a haloacetaldehyde diethyl acetal (III) with a polymer-bound
1 ,2-ethylenediol (II) under acidic conditions to form a polymer-bound haloacetaldehyde acetal (IV),
OEt
Etcr x
Figure imgf000003_0002
IV
2) Reacting said polymer-bound haloacetaldehyde acetal (IV) with a primary amine of the formula R-|NH2 to form a polymer-bound aminoacetaldehyde acetal (V),
Figure imgf000003_0003
(V)
3) Reacting said polymer-bound aminoacetaldehyde acetal (V) with an isocyanate of the formula R2NCO to form a polymer-bound urea acetaldehyde acetal (VI), and,
Figure imgf000003_0004
(VI)
4) Reacting said polymer-bound urea acetaldehyde acetal (VI) with an acid to provide the 2-imidazolone (I), wherein Ri and R2 independently represent hydrogen, alkyl, heterocyclyl, aryl, or heteroaryl groups.
Preferably, said acid in the step 4) is trifluoroacetic acid or hydrochloric acid. In another aspect, this invention also provides a polymer-bound haloacetaldehyde acetal compound of formula (IV), wherein x is chloro, bromo or iodo.
In still another aspect, this invention also provides a process for preparing a polymer-bound haloacetaldehyde acetal compound of formula (IV) by reacting a haloacetaldehyde diethyl acetal (III) with a polymer-bound 1 ,2-ethylenediol under acidic conditions, wherein x is chloro, bromo or iodo.
In still another aspect, this invention also provides a polymer-bound aminoacetaldehyde acetal compound of formula (V), wherein Ri represents hydrogen, alkyl, heterocyclyl, aryl, or heteroaryl groups.
In still another aspect, this invention also provides a process for preparing a polymer-bound aminoacetaldehyde acetal compound of formula (V) by reacting a polymer-bound haloacetaldehyde acetal (IV) with a primary amine of the formula
RιNH2, wherein Ri represents hydrogen, alkyl, heterocyclyl, aryl, or heteroaryl groups.
DETAILED DESCRIPTION OF THE INVENTION
The detailed description of the invention which follows is not intended to be exhaustive or to limit the invention to the precise details or examples disclosed. Details and examples have been chosen to explain the invention to others skilled in the art.
The processes of this invention described herein and in the claims, may be performed in several ways. Preferred methodologies are described as follows.
Under acidic conditions, reaction of a haloacetaldehyde diethyl acetal with a polymer-bound 1 ,2-ethylenediol affords the polymer-bound haloacetaldehyde acetal (IV). The acids that make acidic conditions in this reaction include but not limited to p-toluenesulfonic acid, camphor sulfonic acid, hydrochloric acid and Lewis acids.
The preferred acid is camphor sulfonic acid.
The polymer-bound 1 ,2-ethylenediol is purchased from commercial sources
(e.g. polymer-bound glycerol) or may be prepared from a polymer through derivatization. For instance, a polymer-bound glycerol can be prepared from a polymer and a glycerol derivative (Lenzoff, C.C. et al., Can. J. Chem. 51 ,
3756(1973)). Reaction of a polymer-bound haloacetaldehyde acetal (IV) with a primary amine of the formula R1NH2 in a solvent forms a polymer-bound aminoacetaldehyde acetal (V). There is no restriction on the solvent used for this reaction step, except that the amine RiNH2 be at least somewhat soluble therein. For example, most organic solvents such as DMSO, DMF or toluene can be utilized successfully for the reaction. However, DMSO is the preferred solvent. Preferably, the reaction is conducted at the elevated temperature, for example, at 80°C.
Reaction of a polymer-bound aminoacetaldehyde acetal (V) with isocyanates of the formula R2NCO gives a urea acetaldehyde acetal intermediate (VI) under a variety of conditions. The reaction goes smoothly in solvents such as THF, CH2CI2 or toluene. The reaction can be conducted in the presence or absence of bases. In order to ensure the completion of the reaction with relatively unreactive isocyanates or sterically hindered substituents on the polymer-bound aminoacetaldehyde acetal, the reaction was preferably conducted at 60°C in toluene in the presence of DMAP or DIPEA.
Treatment of a urea acetaldehyde acetal intermediate (VI) with an acid gives the desired 2-imidazolone (I) in good yields and purity. The preferred acid is trifluoroacetic acid (TFA). Purification of the final product can be done with conventional purification procedure. These steps provide a traceiess solid-phase synthesis of 2-imidazolones.
The process described in the invention could be useful for making a large number of compounds for, but not limited to, high-throughput screening. One of the potential advantages of this reaction is that it yields a reusable polymer along with the product. This invention also provides a polymer-bound haloacetaldehyde acetal compound of formula (IV), wherein x is chloro, bromo or iodo, which may be prepared by the process described throughout this specification. This polymer- bound haloacetaldehyde is a useful intermediate in preparing compounds with aldehyde functionalities or the like. The process for making a polymer-bound haloacetaldehyde acetal compound of formula (IV) by reacting a haloacetaldehyde diethyl acetal (III) with a polymer-bound 1 ,2-ethylenediol under acidic conditions is performed according to descriptions throughout this specification.
This invention also provides a polymer-bound aminoacetaldehyde acetal compound of formula (V), wherein Ri represents hydrogen, alkyl, heterocyclyl, aryl, or heteroaryl groups, which is a useful intermediate in preparing compounds with aldehyde and/or amino functionalities.
The process for preparing the polymer-bound aminoacetaldehyde acetal compound of formula (V) by reacting a polymer-bound haloacetaldehyde acetal (IV) with a primary amine of the formula R1NH2, wherein Ri represents hydrogen, alkyl, heterocyclyl, aryl, or heteroaryl groups, is conducted according to descriptions throughout this specification.
DEFINITIONS Generally and for illustration purposes, the parent 2-imidazolone ring structure is IUPAC numbered as follows:
0
\ — / 4 5
As used above, and throughout the description of the invention, the following terms, unless otherwise indicated, shall be understood to have the following meanings:
"Acid", as used herein, means an acid that facilitates acetal hydrolysis. It includes organic acids such as trifluoroacetic acid, p-toluenesulfonic acid, acetic acid, formic acid or inorganic acids such as hydrohalic acids. The preferred acid in the invention for the cleavage (hydrolysis) of acetal functionality from the solid support is trifluoroacetic acid or hydrochloric acid.
"Acid labile linkage", as used herein, means the link between an organic molecule and a solid support (or polymer, resin) can be removed or cleaved by treatment with an acid while remaining stable to other reagents. Examples of acid labile linkage include ether or ester bond on Wang resin (Wang, S.-S. J. Am. Chem. Soc. 95, 1328 (1973)), amide bond on Rink resin (Rink, H., Tetrahedron Lett. 28, 3787 (1987)), or acetal on the polymer as described in the invention. Preferred acids to cleave the product from these polymers (resins) are trifluoroacetic acid (TFA) or HF.
"Alkyl", as used herein, means a cyclic, branched, or straight chain chemical group containing only carbon and hydrogen, such as methyl, pentyl, and adamantyl. Alkyl groups can either be unsubstituted or substituted with one or more substituents, e.g., halogen, alkoxy, acyloxy, amino, cyano, nitro, hydroxyl, mercapto, carboxy, benzyloxy, aryl, heteroaryl, or other functionality that may be suitably blocked, if necessary for purposes of the invention, with a protecting group. Alkyl groups can be saturated or unsaturated (e.g., containing -C=C- or -CΞC- subunits), at one or several positions. Typically, alkyl groups will comprise 1 to 12 carbon atoms, preferably 1 to 10, and more preferably 1 to 8 carbon atoms.
"Aryl", as used herein, means a monovalent unsaturated aromatic carbocyclic group having a single-ring (e.g., phenyl) or multiple condensed rings (e.g., naphthyl or anthryl), which can be optionally unsubstituted or substituted with amino, cyano, hydroxyl, lower alkyl, haloalkyl, alkoxy, nitro, halo, mercapto, and other substituents.
"Halo", as used herein, means chloro, bromo or iodo atoms in the invention. The fluorine atom is excluded in the invention.
"Heteroaryl", as used herein, means a monovalent unsaturated aromatic carbocyclic group having a single ring (e.g., pyrridyl or furyl) or multiple condensed rings (e.g., indolizinyl or benzothienyl) and having at least one hetero atom, such as N, O, or S, within the ring, which can optionally be unsubstituted or substituted with amino, cyano, nitro, hydroxyl, alkyl, haloalkyl, alkoxy, aryl, halo, mercapto, and other substituents. "Heterocyclyl", as used herein, means radical heterocycles which are saturated, or unsaturated and non-aromatic. These may be substituted or unsubstituted, and are attached to the core structure via any available valence, preferably any available carbon. More preferred heterocycles are of 5 or 6 members. In six membered non-aromatic monocyclic heterocycles, the heteroatom(s) are from one to three Ns, and wherein when the heterocycle is five membered and non-aromatic, preferably it has one or two heteroatoms selected from O, N, or S. "Polymer-bound 1 ,2-ethylenediol", as used herein, means that 1 ,2-dihydroxyl ethane unit is linked through an ethylene carbon to a polymer via any stable linkage. For example, polymer-bound glycerol that linked glycerol to the polymer through a stable ether bond is regarded as a polymer-bound 1 ,2-ethylenediol. "Protecting group", as used herein, means a chemical group that exhibits the following characteristics: (I) reacts selectively with the desired functionality in good yield to give a protected substrate that is stable to the projected reactions for which protection is desired; 2) is selectively removable from the protected substrate to yield the desired functionality; and 3) is removable in good yield by reagents compatible with the other functional group(s) generated in such protected reactions. Examples of protecting groups can be found in Greene and Wuts, Protective Groups in Organic Synthesis, 2nd Ed. John Wiley & Sons, (1991 ).
"Solid-phase synthesis", as used herein, means a heterogeneous reaction in which one of reactants is covalently connected to a solid support (polymer or resin, etc.). Other reactants are dissolved in an organic solvent or solvents and the product is obtained through a cleavage step from the solid support.
"Solid support", as used herein, means a substrate which is inert to the reagents and reaction conditions described herein, as well as being substantially insoluble in the media used. Representative solid supports include inorganic substrates such as kieselguhr, silica gel, and controlled pore glass; organic polymers including polystyrene, polypropylene, polyethylene glycol, polyacrylamide, cellulose, and the like; and composite inorganic/polymeric compositions such as polyacrylamide supported within a matrix of kieselguhr particles. See J.M. Stewart and J.D. Young, Solid Phase Peptide Synthesis, 2nd. Ed., Pierce Chemical Co. (Chicago, IL, 1984). A polymer is preferably used in this invention. In addition, "solid support" includes polymeric supports such as the polyethylene glycol supports described by Janda et al., Proc. Natl. Acad. Sci. USA, 92, 6419-6423 (1995) and S. Brenner, WO 95/16918, which are soluble in many solvents but can be precipitated
by the addition of a precipitating solvent. The solid support is designated as ^-^ in this specification.
"Solvent", as herein used, means a liquid that can dissolve another compound and has no adverse effect on the reaction or on the reagents involved. Examples of suitable solvents include alcohols (methanol, 1 -butanol, phenol, trifluoroethanol, hexafluoro-2-propanol, etc.), hydrocarbons (benzene, toluene, etc.), amides (dimethyl acetamide, dimethylformamide, etc.), halides (dichloromethane, dichloroethane, etc.), and ethers (tetrahydrofuran, dioxane, etc.). Other solvents include water, 1 -methyl-2-pyrrolιdine, diethyl phosphite, tetramethaylsulphone, dimethyl sulphoxide, acetonitrile and pyridine.
"Traceiess solid-phase synthesis", as used herein, means that a solid-phase synthesis that leaves no trace of the linker used for tethering the starting building blocks to the solid support. "Under acidic conditions", as used herein, means the acetal formation reaction is conducted in the presence of an acid which itself is not part of the reactant. The acid can be either inorganic acids such as hydrochloric acid, sulfuric acid or Lewis acids or organic acids such as trifluoroacetic acid, p-toluenesulfonic acid, camphor sulfonic acid. Preferred acids are camphor sulfonic acid or any Lewis acids.
The following abbreviations have the indicated meanings:
Bn = benzyl
CDCI3= deutered chloroform
CD3OD= deutered methanol CH2Cl2 = dichloromethane
CSA = camphor sulfonic acid
DIPEA = diisopropylethyl amine
DMAP= 4-(dimethylamino)-pyridine
DMF= N,N-dimethylformamide DMSO = dimethylsulfoxide
ESIMS = electron spray mass spectrometry
EtOAc = ethyl acetate
HCI = hydrochloric acid
HF = hydrofluoric acid MeOH = methanol
MgSO = magnesium sulfate
PDE = phosphordiesterase Ph = phenyl
TFA = trifluoroacetic acid THF= tetrahydrofuran TLC = thin layer chromatography The following alkyl group abbreviations are used.
Me = methyl Et = ethyl n-Bu = normal butyl
EXAMPLES
To further illustrate this invention, the following examples are included. The examples should not, of course, be construed as specifically limiting the invention.
Variations of these examples within the scope of the claims are within the purview of one skilled in the art are considered to fall within the scope of the invention as described, and claimed herein. The reader will recognize that the skilled artisan, armed with the present disclosure, and skill in the art is able to prepare and use the invention without exhaustive examples.
Trademarks used herein are examples only and reflect illustrative materials used at the time of the invention. The skilled artisan will recognize that variations in lot, manufacturing processes, and the like, are expected. Hence the examples, and the trademarks used in them are non-limiting, and they are not intended to be limiting, but are merely an illustration of how a skilled artisan may choose to perform one or more of the embodiments of the invention. H nuclear magnetic resonance spectra (NMR) is measured in CDCI3 or other solvents as indicated by a Varian NMR spectrometer (Unity Plus 400, 400 MHz for 1H) unless otherwise indicated and peak positions are expressed in parts per million (ppm) downfield from tetramethylsilane. The peak shapes are denoted as follows, s, singlet; d, doublet; t, triplet; m, multiplet.
Example 1
The 2-imidazolone compounds of the invention are prepared according to the following scheme (Example Scheme 1 ). Example Scheme 1
Figure imgf000011_0001
Figure imgf000011_0002
DMAP or DIPEA
VI
: polymer
The polymer that used in the reaction is a commercially available polymer- bound glycerol (II). Acetal exchange of a haloacetaldehyde diethyl acetal such as bromoacetaldehyde diethyl acetal with the polymer-bound glycerol affords the polymer-bound haloacetaldehyde acetal (IV) in the presence of camphor sulfonic acid in CH2CI2 at room temperature. The formation of the halide on the solid support is confirmed by infrared spectrometric analysis and weight change of the resin. Amination of the intermediate bromoacetaldehyde acetal (IV) with a primary amine of the formula R1 NH2 in DMSO afforded the desired aminoacetaldehyde acetal (V) on the solid support. The reaction is conducted at 80°C.
Reaction of the polymer-bound aminoacetaldehyde acetal (V) with isocyanates of the formula R2NCO gave the corresponding urea acetaldehyde acetal (VI) in the presence of DIPEA or DMAP in toluene at 60°C. Finally, treatment of the urea acetaldehyde acetal (VI) with trifluoroacetic acid (TFA) released the corresponding urea acetaldehyde, which spontaneously cyclized to give the desired 2-imidazolone (I) in good yield and purity.
Example 2
Preparation of N-benzyl-N'-(m-methoxyphenyl)-imidazol-2-one (VII)
Figure imgf000012_0001
VII
CSA (1 eq.) was added followed by 2-bromoacetaldehyde diethyl acetal (10 eq) to the suspension of polymer-bound glycerol (250 mg, 1.38 mmol/g, Aldrich) in CH2CI2 (3 mL) in a 10 mL tube with frit and screw cap. The suspension was shaken in a shaker at room temperature for 12 h. The solvent was drained, and the polymer was washed with DMF (3 x 6 mL), MeOH (3 x 6 mL) and CH2CI2 (3 x 6 mL) and dried under vacuum at room temperature.
To the suspension of the dried polymer-bound bromoacetaldehyde in DMSO (3 mL) was added benzylamine (6 mmol) at room temperature. The reaction suspension was then heated in an oven shaker at 80°C for 16 h. The solvent was drained and the polymer was washed and dried as described above to give the resin-bound aminoacetaldehyde acetal.
To the polymer-bound aminoacetaldehyde acetal suspended in toluene (3 mL) was added m-methoxyphenylisocyanate (10 eq) and DMAP (1 eq). The suspension was heated to 60°C in the oven shaker for 6 h. After washing and drying, the polymer was cleaved with 20% TFA in CH2CI2 followed by 50% TFA in H2O to afford the crude product. Further purification by preparative TLC (30% ethyl acetate in hexanes) gave the Λ/-benzyl-Λ/'-(m-methoxylphenyl)-2-imidazolone in 61 % yield. 1H NMR 57.5 (d, 1 H), 7.3 (m, 6H), 7.0 (m, 2H), 6.4 (d, 1 H), 6.2 (d, 2H), 4.8 (s, 2H), 3.8 (s, 3H). ESIMS: m/ 281 (M+H), Cι76N202.
Example 3
The following compounds were prepared according to method described in the above examples.
Figure imgf000012_0002
Figure imgf000013_0001

Claims

We claim:
1. A process for preparing a 2-imidazolone compound of the formula
Figure imgf000014_0001
comprising the steps of
1 ) Reacting a haloacetaldehyde diethyl acetal with a polymer-bound 1 ,2- ethylenediol under acidic conditions to form a , polymer-bound haloacetaldehyde acetal,
2) Reacting said polymer-bound haloacetaldehyde acetal with a primary amine of the formula Ri NH2 to form a polymer-bound aminoacetaldehyde acetal,
3) Reacting said polymer-bound aminoacetaldehyde acetal with an isocyanate of the formula R2NCO to form a pblymer-bound urea acetaldehyde acetal, and,
4) Reacting said polymer-bound urea acetaldehyde acetal with an acid to provide the 2-imidazolone, wherein
Ri and R2 independently represent hydrogen, alkyl, heterocyclyl, aryl, or heteroaryl groups.
2. The process of claim 1 , wherein said acid in step 4) is trifluoroacetic acid or hydrochloric acid.
3. A polymer-bound haloacetaldehyde acetal compound of formula
,0- oof X
wherein x is chloro, bromo or iodo.
4. A process for preparing a polymer-bound haloacetaldehyde acetal compound of the formula -
by reacting the haloacetaldehyde diethryl axcetal with a polymer-bound 1 ,2- ethylenediol under acidic conditions, wherein x is chloro, bromo or iodo.
5. A polymer-bound aminoacetaldehyde acetal compound of the formula
Figure imgf000015_0001
wherein Ri represents hydrogen, alkyl, heterocyclyl, aryl, or heteroaryl groups.
6. A process for preparing a polymer-bound aminoacetaldehyde acetal compound of the formula
Figure imgf000015_0002
by reacting a polymer-bound haloacetaldehyde acetal with a primary amine of the formula R-(NH2, wherein Ri represents hydrogen, alkyl, heterocyclyl, aryl, or heteroaryl groups.
PCT/US2001/027207 2000-09-06 2001-08-31 A traceless solid-phase synthesis of 2-imidazolones WO2002020493A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001288605A AU2001288605A1 (en) 2000-09-06 2001-08-31 A traceless solid-phase synthesis of 2-imidazolones

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23032300P 2000-09-06 2000-09-06
US60/230,323 2000-09-06

Publications (2)

Publication Number Publication Date
WO2002020493A2 true WO2002020493A2 (en) 2002-03-14
WO2002020493A3 WO2002020493A3 (en) 2002-10-31

Family

ID=22864766

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/027207 WO2002020493A2 (en) 2000-09-06 2001-08-31 A traceless solid-phase synthesis of 2-imidazolones

Country Status (2)

Country Link
AU (1) AU2001288605A1 (en)
WO (1) WO2002020493A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008046758A2 (en) * 2006-10-19 2008-04-24 F. Hoffmann-La Roche Ag Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
US8263635B2 (en) 2009-06-26 2012-09-11 Novartis Ag Inhibitors of CYP 17
US9029399B2 (en) 2011-04-28 2015-05-12 Novartis Ag 17α-hydroxylase/C17,20-lyase inhibitors

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2707186A (en) * 1954-05-06 1955-04-26 Hoffmann La Roche Imidazolone derivatives
US3216816A (en) * 1960-10-13 1965-11-09 Du Pont Herbicidal composition and method
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
WO2000034263A1 (en) * 1998-12-08 2000-06-15 H. Lundbeck A/S Benzofuran derivatives, their preparation and use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2707186A (en) * 1954-05-06 1955-04-26 Hoffmann La Roche Imidazolone derivatives
US3216816A (en) * 1960-10-13 1965-11-09 Du Pont Herbicidal composition and method
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
WO2000034263A1 (en) * 1998-12-08 2000-06-15 H. Lundbeck A/S Benzofuran derivatives, their preparation and use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JAMES I W: "Linkers for Solid Phase Organic Synthesis" TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 55, no. 16, 16 April 1999 (1999-04-16), pages 4855-4946, XP004161079 ISSN: 0040-4020 *
KRAXNER JOHANNES ET AL: "Traceless linking of indoles. General methodology and application to solid phase supported Mannich and Stille reactions" SYNLETT, THIEME VERLAG, STUTTGART, DE, 2000, pages 125-127, XP002171484 ISSN: 0936-5214 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008046758A2 (en) * 2006-10-19 2008-04-24 F. Hoffmann-La Roche Ag Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
WO2008046758A3 (en) * 2006-10-19 2009-06-11 Hoffmann La Roche Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
JP2010506876A (en) * 2006-10-19 2010-03-04 エフ.ホフマン−ラ ロシュ アーゲー Imidazolone and imidazolidinone derivatives as 11β-HSD1 inhibitors for diabetes
EP2308851A1 (en) * 2006-10-19 2011-04-13 F. Hoffmann-La Roche AG Imidazolone and imidazolidinone derivatives as 11B-HSD1 inhibitors for the treatment of diabetes
US8129423B2 (en) 2006-10-19 2012-03-06 Hoffman-La Roche Inc. Imidazolone and imidazoloidinone derivatives as 11b-HSD1 inhibitors
US8263635B2 (en) 2009-06-26 2012-09-11 Novartis Ag Inhibitors of CYP 17
USRE45173E1 (en) 2009-06-26 2014-09-30 Novartis Ag Inhibitors of CYP 17
US9029399B2 (en) 2011-04-28 2015-05-12 Novartis Ag 17α-hydroxylase/C17,20-lyase inhibitors
US9339501B2 (en) 2011-04-28 2016-05-17 Novartis Ag 17a-hydroxylase/C17,20-lyase inhibitors

Also Published As

Publication number Publication date
AU2001288605A1 (en) 2002-03-22
WO2002020493A3 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
US9035061B2 (en) Process for preparing a biphenyl-2-ylcarbamic acid
KR20170102887A (en) Synthesis of a bruton's tyrosine kinase inhibitor
SK11982003A3 (en) Method for the production of 4,6-diaminopyrimido[5,4-d]pyrimidines
US6844434B2 (en) Synthesis of temozolomide and analogs
KR102477924B1 (en) Methods for preparing indole carboxamide compounds
WO2002020493A2 (en) A traceless solid-phase synthesis of 2-imidazolones
US7683170B2 (en) Methods for preparing Irinotecan
KR100705363B1 (en) Intermediates for the Production of Naphthyridine-3-Carboxylic Acid Derivatives
WO1998016508A2 (en) Synthesis of aromatic compounds by diels-alder reaction on solid support
KR102702677B1 (en) Process for Preparation of Fimasartan and Intermediate for Preparing the Same
WO2001002375A1 (en) Process for synthesizing oxadiazoles
US20050113514A1 (en) 4-N-acyl-delta 5-2-oxopiperazines, a process for its preparation and combinatorial libraries thereof
KR20090116753A (en) New process for preparing 3-methyl-4-phenylisoxazolo[3,4-d]pyridazin-7(6h)-one
CN108610306B (en) Synthetic method of 2H-1, 4-thiazine-3 (4H) -ketone derivative
KR101529963B1 (en) Method for preparing everolimus and its intermediates
US5302722A (en) 3-carboxy-pyrrole derivatives
WO2019008595A1 (en) Process for the preparation of 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1- methylpiperidin-4-yl)urea and salts thereof
US20040039210A1 (en) Process for preparation of n-substituted 2-sulfanylimidazoles
KR100712667B1 (en) New diaza-bridged heterocycle derivatives and solid-phase preparation method thereof
KR101858953B1 (en) Synthetic method for C-3 functionalized imidazopyridine
JP4176163B2 (en) Process for producing 1-{[2- (cyclopropylcarbonyl) phenyl] sulfamoyl} -3- (4,6-dialkoxy-2-pyrimidinyl) urea compound and intermediate for the production
HU210517B (en) Process for preparation of 2-pyridyl-sulphonyl-urea derivatives
WO2002079172A1 (en) Method for preparing monocyclic $i(n)-acyl-aminolactam compounds and combinatorial libraries thereof
US6177520B1 (en) Organic compounds
JPH04210984A (en) Preparation of cyclized iminothiazole, and intermediate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP